封面
市场调查报告书
商品编码
1890942

主动脉瘤市场:按动脉瘤位置、治疗方法、产品类型、诊断方法、年龄层、性别、最终用户、通路和地区划分

Aortic Aneurysm Market, By Aneurysm Location, By Treatment Type, By Product Type, By Diagnosis Type, By Age Group, By Gender, By End User, By Distribution Channel, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3个工作天内

价格
简介目录

主动脉瘤市场预计在 2025 年达到 49.4 亿美元,预计到 2032 年将达到 112.7 亿美元,2025 年至 2032 年的复合年增长率为 12.5%。

报告覆盖范围 报告详情
基准年: 2024 2025年市场规模: 49.4亿美元
历史数据时期: 2020年至2024年 预测期: 2025年至2032年
预测期(2025-2032年)复合年增长率: 12.50% 预计2032年价值: 112.7亿美元

全球主动脉瘤市场是心血管医疗设备业的重要组成部分,它致力于治疗影响全球数百万人的最危及生命的血管疾病之一。

主动脉瘤是指人体最大动脉-主动脉的血管壁变薄并向外凸出,若不及时治疗,可能危及生命。该市场涵盖一系列全面的诊断工具、手术器械、血管内血管支架以及微创治疗方案,旨在检测、监测和修復这些危险的动脉扩张。随着全球人口老化以及心血管疾病、高血压和动脉粥状硬化盛行率的不断上升,对先进的主动脉瘤治疗方案的需求持续增长。

该市场涵盖各种解剖位置,包括胸主动脉瘤 (TAA) 和腹部主动脉血管瘤(AAA),每一种都需要专门的治疗方法和设备技术。

血管内动脉瘤修復术(EVAR)技术、开窗式和分支式血管支架以及混合手术技术的创新显着改善了患者的预后,同时降低了手术风险。为了应对日益严重的主动脉瘤疾病负担,全球医疗系统正在增加对筛检计画、先进影像技术和专科治疗中心的投入,这推动了市场显着增长和技术进步。

市场动态

全球主动脉瘤市场的成长主要受多种强劲因素驱动,这些因素共同支撑着市场稳健成长。全球人口老化是其中最重要的驱动因素,因为老龄化与动脉壁退化和心血管危险因子累积导致的主动脉瘤发生率增加直接相关。高血压、糖尿病、吸烟和动脉粥状硬化性疾病的日益普遍进一步刺激了市场需求,而血管内修復技术的突破,包括开窗血管支架和复杂分叉装置,正在提高治疗的可及性和改善患者预后。

医护人员和患者对筛检通讯协定的认识不断提高,以及CT血管造影术和超音波技术等诊断影像能力的改进,正在促进早期发现和介入率的提高。

然而,目前仍有许多市场限制,包括先进的血管内介入器械和手术高成本,这限制了发展中地区的医疗服务获取,并给医疗系统的报销带来挑战。创新医疗设备复杂的监管核准流程可能会延迟其上市时间,并增加製造商的研发成本。此外,血管内介入手术可能出现的併发症,例如内漏、器械移位以及对长期耐用性的担忧,也会限制较保守的医疗机构的采用率。

儘管面临这些挑战,新兴市场医疗基础设施的扩建、政府加大心血管疾病预防主导以及医疗旅游业的蓬勃发展,都带来了巨大的机会。可生物降解支架技术、人工智慧辅助手术规划以及基于基因分析的个人化治疗方案的开发,为市场拓展和创新提供了广阔的前景。

本次调查的主要特点

  • 本报告对全球主动脉瘤市场进行了详细分析,以 2024 年为基准年,给出了预测期(2025-2032 年)内的市场规模(十亿美元)和復合年增长率(%)。
  • 它重点介绍了各个细分市场的潜在商机,并说明了该市场具有吸引力的投资提案矩阵。
  • 该研究还提供了有关市场驱动因素、限制因素、机会、新产品发布或核准、市场趋势、区域展望以及主要企业的竞争策略的重要见解。
  • 该报告根据以下参数对全球主动脉瘤市场的主要企业进行了分析:公司概况、产品系列、主要亮点、财务表现和策略。
  • 本报告的研究结果将使负责人和企业经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
  • 这份全球主动脉瘤市场报告的目标受众是该行业的各类相关人员,包括投资者、供应商、产品製造商、经销商、新参与企业和金融分析师。
  • 相关人员可以透过全球主动脉瘤市场分析中使用的各种策略矩阵轻鬆做出决策。

目录

第一章 研究目标与前提条件

  • 调查目的
  • 先决条件
  • 简称

第二章 市场范围

  • 报告概述
    • 市场定义和范围
  • 执行摘要

第三章 市场动态、监理及趋势分析

  • 市场动态
  • 司机
  • 抑制因素
  • 机会
  • 影响分析
  • 重大进展
  • 法规环境
  • 产品上市及核准
  • PEST分析
  • 波特分析
  • 併购趋势
  • 产业趋势

4. 2020-2032年全球主动脉瘤市场(依动脉瘤部位划分)

  • 腹部主动脉血管瘤
  • 胸主动脉瘤
  • 腹部主动脉血管瘤

5. 2020-2032年全球主动脉瘤市场(依治疗方法)

  • 开放性手术修復
  • 血管内治疗

6. 2020-2032年全球主动脉瘤市场(依产品类型划分)

  • 血管支架
  • 导管
  • 导管导引线
  • 球囊血管成形术装置
  • 其他血管内附件

7. 2020-2032年全球主动脉瘤市场(依诊断方法划分)

  • 超音波(筛检和监测)
  • 电脑断层血管造影术(CTA)
  • 磁振血管造影术(MRA)
  • 常规导管血管血管造影术
  • 血管内超音波(IVUS)/术中影像

8. 2020-2032年全球主动脉瘤市场(依年龄层划分)

  • 60岁以下
  • 60至75岁
  • 75岁或以上

9. 2020-2032年全球主动脉瘤市场(依性别划分)

  • 男性
  • 女士

10. 2020-2032年全球主动脉瘤市场(依最终用户划分)

  • 医院
  • 专科心血管中心
  • 门诊手术中心
  • 诊断影像中心
  • 研究和学术机构

11. 2020-2032年全球主动脉瘤市场(依通路划分)

  • 在线的
  • 离线

12. 2020-2032年全球主动脉瘤市场(按地区划分)

  • 北美洲
    • 美国
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 墨西哥
    • 其他拉丁美洲国家
  • 欧洲
    • 德国
    • 英国
    • 西班牙
    • 法国
    • 义大利
    • 俄罗斯
    • 其他欧洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳洲
    • 韩国
    • ASEAN
    • 亚太其他地区
  • 中东
    • 海湾合作委员会国家
    • 以色列
    • 其他中东国家
  • 非洲
    • 南非
    • 北非
    • 中非

第十三章 竞争格局

  • Medtronic plc
  • Cook Medical LLC
  • L. Gore and Associates Inc.
  • Terumo Corporation
  • Endologix LLC
  • Cardinal Health Inc.
  • Becton Dickinson and Company(BD)
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Braun Melsungen AG
  • JOTEC GmbH(CryoLife/Artivion)
  • Lombard Medical Technologies
  • Cordis(a Cardinal Health company/Cordis Inc.)
  • Merit Medical Systems Inc.
  • LeMaitre Vascular Inc.

第十四章 分析师建议

  • 机会
  • 分析师观点
  • Coherent Opportunity Map

第十五章 参考文献与调查方法

  • 参考
  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI8957

Aortic Aneurysm Market is estimated to be valued at USD 4.94 Bn in 2025 and is expected to reach USD 11.27 Bn by 2032, growing at a compound annual growth rate (CAGR) of 12.5% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 4.94 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 12.50% 2032 Value Projection: USD 11.27 Bn

The global aortic aneurysm market represents a critical segment within the cardiovascular medical device industry, addressing one of the most life-threatening vascular conditions affecting millions worldwide.

An aortic aneurysm occurs when the wall of the aorta, the body's largest artery, weakens and bulges outward, creating a potentially fatal condition if left untreated. The market encompasses a comprehensive range of diagnostic tools, surgical devices, endovascular stent grafts, and minimally invasive treatment solutions designed to detect, monitor, and repair these dangerous arterial dilations. With aging populations globally experiencing increased prevalence of cardiovascular diseases, hypertension, and atherosclerosis, the demand for advanced aortic aneurysm management solutions continues to escalate.

The market spans various anatomical locations including thoracic aortic aneurysms (TAA) and abdominal aortic aneurysms (AAA), each requiring specialized therapeutic approaches and device technologies.

Innovation in endovascular aneurysm repair (EVAR) techniques, fenestrated and branched stent grafts, and hybrid surgical procedures has revolutionized patient outcomes while reducing procedural risks. Healthcare systems worldwide are increasingly investing in screening programs, advanced imaging technologies, and specialized treatment centers to address the growing burden of aortic aneurysmal disease, driving substantial market growth and technological advancement.

Market Dynamics

The global aortic aneurysm market growth is primarily driven by several compelling factors that collectively fuel its robust growth trajectory. The aging global population represents the most significant driver, as advanced age correlates directly with increased aortic aneurysm incidence due to arterial wall degeneration and accumulated cardiovascular risk factors. Rising prevalence of hypertension, diabetes, smoking, and atherosclerotic diseases further amplifies market demand, while technological breakthroughs in endovascular repair techniques, including fenestrated stent grafts and complex branched devices, enhance treatment accessibility and patient outcomes.

Growing awareness among healthcare professionals and patients about screening protocols, coupled with improved diagnostic imaging capabilities such as CT angiography and ultrasound technologies, drives early detection and intervention rates.

However, the market faces notable restraints including the high cost of advanced endovascular devices and surgical procedures, which limit accessibility in developing regions and create reimbursement challenges for healthcare systems. Complex regulatory approval processes for innovative medical devices can delay market entry and increase development costs for manufacturers. Additionally, potential complications associated with endovascular procedures, including endoleaks, device migration, and long-term durability concerns, may restrict adoption rates among conservative practitioners.

Despite these challenges, significant opportunities emerge through expanding healthcare infrastructure in emerging markets, increasing government initiatives for cardiovascular disease prevention, and growing medical tourism sectors. The development of biodegradable stent technologies, artificial intelligence-guided surgical planning, and personalized treatment approaches based on genetic profiling present lucrative avenues for market expansion and innovation.

Key Features of the Study

  • This report provides in-depth analysis of the global aortic aneurysm market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global aortic aneurysm market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Medtronic plc, Cook Medical LLC, W. L. Gore and Associates Inc., Terumo Corporation, Endologix LLC, Cardinal Health Inc., Becton Dickinson and Company (BD), Abbott Laboratories, Boston Scientific Corporation, Braun Melsungen AG, JOTEC GmbH (CryoLife / Artivion), Lombard Medical Technologies, Cordis (a Cardinal Health company / Cordis Inc.), Merit Medical Systems Inc., and LeMaitre Vascular Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global aortic aneurysm market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global aortic aneurysm market

Market Segmentation

  • Aneurysm Location Insights (Revenue, USD Bn, 2020 - 2032)
    • Abdominal Aortic Aneurysm
    • Thoracic Aortic Aneurysm
    • Thoracoabdominal Aortic Aneurysm
  • Treatment Type Insights (Revenue, USD Bn, 2020 - 2032)
    • Open Surgical Repair
    • Endovascular Aneurysm Repair
  • Product Type Insights (Revenue, USD Bn, 2020 - 2032)
    • Stent Grafts
    • Catheters
    • Guidewires
    • Balloon Angioplasty Devices
    • Other Endovascular Accessories
  • Diagnosis Type Insights (Revenue, USD Bn, 2020 - 2032)
    • Ultrasound (Screening & Surveillance)
    • Computed Tomography Angiography (CTA)
    • Magnetic Resonance Angiography (MRA)
    • Conventional Catheter Angiography
    • Intravascular Ultrasound (IVUS)/Intraoperative Imaging
  • Age Group Insights (Revenue, USD Bn, 2020 - 2032)
    • Below 60 Years
    • 60-75 Years
    • Above 75 Years
  • Gender Insights (Revenue, USD Bn, 2020 - 2032)
    • Male
    • Female
  • End User Insights (Revenue, USD Bn, 2020 - 2032)
    • Hospitals
    • Specialty Cardiac and Vascular Centers
    • Ambulatory Surgical Centers
    • Diagnostic Imaging Centers
    • Research and Academic Institutes
  • Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
    • Online
    • Offline
  • Regional Insights (Revenue, USD Bn, 2020 - 2032)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Medtronic plc
    • Cook Medical LLC
    • L. Gore and Associates Inc.
    • Terumo Corporation
    • Endologix LLC
    • Cardinal Health Inc.
    • Becton Dickinson and Company (BD)
    • Abbott Laboratories
    • Boston Scientific Corporation
    • Braun Melsungen AG
    • JOTEC GmbH (CryoLife / Artivion)
    • Lombard Medical Technologies
    • Cordis (a Cardinal Health company / Cordis Inc.)
    • Merit Medical Systems Inc.
    • LeMaitre Vascular Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Aortic Aneurysm Market, By Aneurysm Location
    • Global Aortic Aneurysm Market, By Treatment Type
    • Global Aortic Aneurysm Market, By Product Type
    • Global Aortic Aneurysm Market, By Diagnosis Type
    • Global Aortic Aneurysm Market, By Age Group
    • Global Aortic Aneurysm Market, By Gender
    • Global Aortic Aneurysm Market, By End User
    • Global Aortic Aneurysm Market, By Distribution Channel
    • Global Aortic Aneurysm Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Driver
  • Restraint
  • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Industry Trends

4. Global Aortic Aneurysm Market, By Aneurysm Location, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Abdominal Aortic Aneurysm
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Thoracic Aortic Aneurysm
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Thoracoabdominal Aortic Aneurysm
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Aortic Aneurysm Market, By Treatment Type, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Open Surgical Repair
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Endovascular Aneurysm Repair
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Aortic Aneurysm Market, By Product Type, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Stent Grafts
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Catheters
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Guidewires
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Balloon Angioplasty Devices
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Other Endovascular Accessories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Aortic Aneurysm Market, By Diagnosis Type, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Ultrasound (Screening & Surveillance)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Computed Tomography Angiography (CTA)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Magnetic Resonance Angiography (MRA)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Conventional Catheter Angiography
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Intravascular Ultrasound (IVUS)/Intraoperative Imaging
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Aortic Aneurysm Market, By Age Group, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Below 60 Years
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • 60-75 Years
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Above 75 Years
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Aortic Aneurysm Market, By Gender, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Male
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Female
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

10. Global Aortic Aneurysm Market, By End User, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Specialty Cardiac and Vascular Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Diagnostic Imaging Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Research and Academic Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

11. Global Aortic Aneurysm Market, By Distribution Channel, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Online
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Offline
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

12. Global Aortic Aneurysm Market, By Region, 2020 - 2032, Value (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Aneurysm Location, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Treatment Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Diagnosis Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Aneurysm Location, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Treatment Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Diagnosis Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Aneurysm Location, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Treatment Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Diagnosis Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Aneurysm Location, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Treatment Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Diagnosis Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Aneurysm Location, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Treatment Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Diagnosis Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Aneurysm Location, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Treatment Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Diagnosis Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

13. Competitive Landscape

  • Medtronic plc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Cook Medical LLC
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • L. Gore and Associates Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Terumo Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Endologix LLC
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Cardinal Health Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Becton Dickinson and Company (BD)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Abbott Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Boston Scientific Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Braun Melsungen AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • JOTEC GmbH (CryoLife / Artivion)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Lombard Medical Technologies
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Cordis (a Cardinal Health company / Cordis Inc.)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Merit Medical Systems Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • LeMaitre Vascular Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

14. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

15. References and Research Methodology

  • References
  • Research Methodology
  • About us